Koers Galena Biopharma Inc Nasdaq
Aandelen
US3632561086
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | - | Omzet 2025 * | 50,61 mln. 47,48 mln. | Marktkapitalisatie | 69,77 mln. 65,45 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -40 mln. -37,52 mln. | Nettowinst (verlies) 2025 * | -50 mln. -46,9 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,38 x |
K/w-verhouding 2024 * |
-1,09
x | K/w-verhouding 2025 * |
-1,08
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,5% |
Recentste transcriptie over Galena Biopharma Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Angelos Stergiou
FOU | Founder | 48 | 03-04-06 |
John Burns
DFI | Director of Finance/CFO | 39 | 01-05-13 |
Andrew Elnatan
LAW | General Counsel | - | 05-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 67 | 29-12-17 | |
David Scheinberg
BRD | Director/Board Member | 68 | 01-12-17 |
John Varian
BRD | Director/Board Member | 64 | 29-12-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,46% | 102 mld. | |
+1,41% | 96,29 mld. | |
+2,13% | 22,18 mld. | |
-15,84% | 21,2 mld. | |
-9,21% | 18,31 mld. | |
-39,98% | 17,38 mld. | |
-14,65% | 16,36 mld. | |
+4,39% | 13,97 mld. | |
+31,35% | 12,17 mld. |